4
Changes in Ownership
Whitehawk Therapeutics, Inc. Filed Acc 0001415889-25-006678
Options or other derivatives
- Chief Scientific Officer acquired 687,979 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Dornan David Chief Scientific Officer | 2025-03-04 | Grant or award · Stock Option (right to buy) | +687,979 | 687,979 | D: show line 1 in the form |
Loading xslF345X05/form4-03042025_110311.xml…